- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Fibrin-targeting molecular MRI in inflammatory CNS disorders ; day:4 ; month:5 ; year:2022 ; pages:1-13
European journal of nuclear medicine and molecular imaging ; (4.5.2022), 1-13
- Creator
-
Lohmeier, Johannes
Silva, Rafaela V.
Tietze, Anna
Taupitz, Matthias
Kaneko, Takaaki
Prüss, Harald
Paul, Friedemann
Infante-Duarte, Carmen
Hamm, Bernd
Caravan, Peter
Makowski, Marcus R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-022-05807-8
- URN
-
urn:nbn:de:101:1-2022071220213348654258
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:19 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lohmeier, Johannes
- Silva, Rafaela V.
- Tietze, Anna
- Taupitz, Matthias
- Kaneko, Takaaki
- Prüss, Harald
- Paul, Friedemann
- Infante-Duarte, Carmen
- Hamm, Bernd
- Caravan, Peter
- Makowski, Marcus R.
- SpringerLink (Online service)
Other Objects (12)
The German healthcare system
Detection of in vivo atherosclerotic plaque progression with a fibrin-targeted MR contrast agent
Lesion-to-background ratio threshold value of SUVmax of simultaneous [68Ga]Ga-PSMA-11 PET/MRI imaging in patients with prostate cancer
Analyse der Psoriasisarthritis in der qualitativen und quantitativen Perfusionsanalyse mittels Indocyaningrün-verstärkter fluoreszenzoptischer Bildgebung (ICG-FOI) und in der kontrastverstärkten Magnetresonanztomographie
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
The implication of natural killer cells and neutrophils in autoimmune disorders of the central nervous system
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose
Exercise in multiple sclerosis -- an integral component of disease management
The German healthcare system
Detection of in vivo atherosclerotic plaque progression with a fibrin-targeted MR contrast agent
Lesion-to-background ratio threshold value of SUVmax of simultaneous [68Ga]Ga-PSMA-11 PET/MRI imaging in patients with prostate cancer
Analyse der Psoriasisarthritis in der qualitativen und quantitativen Perfusionsanalyse mittels Indocyaningrün-verstärkter fluoreszenzoptischer Bildgebung (ICG-FOI) und in der kontrastverstärkten Magnetresonanztomographie
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
The implication of natural killer cells and neutrophils in autoimmune disorders of the central nervous system
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose
Exercise in multiple sclerosis -- an integral component of disease management
The German healthcare system
Detection of in vivo atherosclerotic plaque progression with a fibrin-targeted MR contrast agent
Lesion-to-background ratio threshold value of SUVmax of simultaneous [68Ga]Ga-PSMA-11 PET/MRI imaging in patients with prostate cancer
Analyse der Psoriasisarthritis in der qualitativen und quantitativen Perfusionsanalyse mittels Indocyaningrün-verstärkter fluoreszenzoptischer Bildgebung (ICG-FOI) und in der kontrastverstärkten Magnetresonanztomographie
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
The implication of natural killer cells and neutrophils in autoimmune disorders of the central nervous system
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose